 Rachel Frank
Concepts (833)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroscopy | 57 | 2025 | 217 | 10.020 |
Why?
| | Shoulder Joint | 50 | 2024 | 172 | 9.550 |
Why?
| | Joint Instability | 36 | 2024 | 165 | 8.920 |
Why?
| | Cartilage, Articular | 21 | 2025 | 311 | 4.790 |
Why?
| | Knee Injuries | 18 | 2022 | 98 | 4.660 |
Why?
| | Knee Joint | 29 | 2025 | 406 | 4.590 |
Why?
| | Tibial Meniscus Injuries | 12 | 2025 | 48 | 4.580 |
Why?
| | Anterior Cruciate Ligament Reconstruction | 16 | 2025 | 143 | 4.470 |
Why?
| | Biological Products | 12 | 2024 | 217 | 4.460 |
Why?
| | Orthopedic Procedures | 19 | 2021 | 212 | 4.330 |
Why?
| | Shoulder Dislocation | 16 | 2023 | 49 | 4.170 |
Why?
| | Menisci, Tibial | 17 | 2025 | 61 | 4.090 |
Why?
| | Anterior Cruciate Ligament Injuries | 16 | 2025 | 157 | 3.650 |
Why?
| | Sports Medicine | 10 | 2023 | 114 | 3.590 |
Why?
| | Tibia | 13 | 2025 | 178 | 3.450 |
Why?
| | Athletic Injuries | 20 | 2023 | 532 | 3.290 |
Why?
| | Bone Transplantation | 13 | 2025 | 87 | 3.290 |
Why?
| | Platelet-Rich Plasma | 13 | 2025 | 32 | 3.280 |
Why?
| | Orthopedics | 12 | 2025 | 143 | 3.110 |
Why?
| | Simulation Training | 6 | 2024 | 108 | 2.950 |
Why?
| | Femoracetabular Impingement | 8 | 2018 | 35 | 2.920 |
Why?
| | Osteotomy | 11 | 2025 | 109 | 2.560 |
Why?
| | Rotator Cuff Injuries | 11 | 2023 | 60 | 2.540 |
Why?
| | Hip Joint | 8 | 2018 | 168 | 2.360 |
Why?
| | Tenodesis | 8 | 2020 | 20 | 2.350 |
Why?
| | Cartilage Diseases | 5 | 2019 | 39 | 2.330 |
Why?
| | Reoperation | 29 | 2023 | 567 | 2.270 |
Why?
| | Arthroplasty | 10 | 2020 | 51 | 2.240 |
Why?
| | Osteoarthritis, Knee | 15 | 2025 | 254 | 2.120 |
Why?
| | Meniscus | 4 | 2023 | 22 | 2.120 |
Why?
| | Allografts | 18 | 2025 | 145 | 2.000 |
Why?
| | Shoulder Injuries | 9 | 2024 | 58 | 1.970 |
Why?
| | Humans | 298 | 2025 | 136965 | 1.950 |
Why?
| | Shoulder | 22 | 2023 | 90 | 1.780 |
Why?
| | Return to Sport | 10 | 2025 | 94 | 1.740 |
Why?
| | Arthroplasty, Replacement, Shoulder | 9 | 2020 | 33 | 1.720 |
Why?
| | Cartilage | 10 | 2025 | 188 | 1.690 |
Why?
| | Computer Simulation | 6 | 2021 | 982 | 1.680 |
Why?
| | Arthroplasty, Replacement, Knee | 8 | 2023 | 362 | 1.630 |
Why?
| | Transplantation, Homologous | 18 | 2025 | 409 | 1.620 |
Why?
| | Sports | 7 | 2023 | 233 | 1.590 |
Why?
| | Tendons | 10 | 2020 | 110 | 1.590 |
Why?
| | Clinical Competence | 8 | 2024 | 1114 | 1.550 |
Why?
| | Suture Anchors | 7 | 2021 | 33 | 1.530 |
Why?
| | Musculoskeletal Diseases | 5 | 2024 | 78 | 1.520 |
Why?
| | Athletes | 7 | 2023 | 425 | 1.480 |
Why?
| | Scapula | 11 | 2023 | 44 | 1.480 |
Why?
| | Acromioclavicular Joint | 3 | 2023 | 11 | 1.480 |
Why?
| | Patient Reported Outcome Measures | 10 | 2025 | 399 | 1.440 |
Why?
| | Tendon Injuries | 5 | 2019 | 66 | 1.380 |
Why?
| | Postoperative Complications | 24 | 2022 | 2622 | 1.370 |
Why?
| | Adult | 126 | 2025 | 37715 | 1.270 |
Why?
| | Second-Look Surgery | 3 | 2025 | 7 | 1.210 |
Why?
| | Femur | 9 | 2025 | 252 | 1.200 |
Why?
| | Treatment Outcome | 49 | 2025 | 10664 | 1.160 |
Why?
| | Young Adult | 50 | 2025 | 13218 | 1.150 |
Why?
| | Humeral Head | 7 | 2023 | 14 | 1.140 |
Why?
| | Male | 158 | 2025 | 67386 | 1.120 |
Why?
| | Bankart Lesions | 4 | 2023 | 9 | 1.100 |
Why?
| | Evidence-Based Medicine | 7 | 2020 | 735 | 1.100 |
Why?
| | Arthroplasty, Subchondral | 4 | 2018 | 7 | 1.090 |
Why?
| | Rotator Cuff | 8 | 2023 | 46 | 1.070 |
Why?
| | Anterior Cruciate Ligament | 9 | 2023 | 78 | 1.060 |
Why?
| | Internship and Residency | 8 | 2024 | 1157 | 1.050 |
Why?
| | Female | 153 | 2025 | 73002 | 1.040 |
Why?
| | Bone Screws | 5 | 2020 | 103 | 1.020 |
Why?
| | Bone Malalignment | 2 | 2025 | 13 | 1.020 |
Why?
| | Middle Aged | 104 | 2025 | 33226 | 1.010 |
Why?
| | Education, Medical, Graduate | 5 | 2019 | 483 | 1.010 |
Why?
| | Joint Dislocations | 2 | 2024 | 49 | 1.010 |
Why?
| | Female Athlete Triad Syndrome | 2 | 2017 | 8 | 1.000 |
Why?
| | Ligaments, Articular | 5 | 2023 | 50 | 1.000 |
Why?
| | Hemiarthroplasty | 3 | 2020 | 8 | 0.970 |
Why?
| | Osteoarthritis | 7 | 2019 | 187 | 0.970 |
Why?
| | Range of Motion, Articular | 17 | 2023 | 391 | 0.950 |
Why?
| | Orthopedic Surgeons | 2 | 2023 | 27 | 0.920 |
Why?
| | Achilles Tendon | 2 | 2023 | 31 | 0.890 |
Why?
| | Follow-Up Studies | 37 | 2021 | 5048 | 0.880 |
Why?
| | Biomechanical Phenomena | 16 | 2023 | 812 | 0.840 |
Why?
| | Blood Loss, Surgical | 2 | 2014 | 99 | 0.840 |
Why?
| | Quadriceps Muscle | 2 | 2023 | 131 | 0.820 |
Why?
| | Cadaver | 13 | 2020 | 284 | 0.820 |
Why?
| | Adolescent | 74 | 2025 | 21471 | 0.790 |
Why?
| | Social Media | 2 | 2024 | 158 | 0.770 |
Why?
| | Venous Thrombosis | 2 | 2022 | 186 | 0.750 |
Why?
| | Retrospective Studies | 56 | 2021 | 15536 | 0.740 |
Why?
| | Lacerations | 1 | 2022 | 35 | 0.730 |
Why?
| | Pain | 6 | 2018 | 750 | 0.730 |
Why?
| | Arthroplasty, Replacement, Hip | 2 | 2014 | 177 | 0.720 |
Why?
| | Golf | 1 | 2020 | 7 | 0.670 |
Why?
| | Bone Resorption | 3 | 2018 | 85 | 0.670 |
Why?
| | Rupture | 8 | 2023 | 88 | 0.660 |
Why?
| | Skiing | 1 | 2021 | 47 | 0.660 |
Why?
| | Radiography | 16 | 2019 | 814 | 0.660 |
Why?
| | Brain Concussion | 4 | 2023 | 575 | 0.640 |
Why?
| | Suture Techniques | 8 | 2019 | 119 | 0.640 |
Why?
| | Hypertension | 12 | 2025 | 1299 | 0.640 |
Why?
| | Hamstring Muscles | 2 | 2018 | 20 | 0.630 |
Why?
| | Aged | 72 | 2025 | 23803 | 0.630 |
Why?
| | Internet | 3 | 2022 | 678 | 0.620 |
Why?
| | Physical Examination | 9 | 2018 | 240 | 0.610 |
Why?
| | Humerus | 7 | 2020 | 39 | 0.600 |
Why?
| | Virtual Reality | 1 | 2019 | 61 | 0.570 |
Why?
| | Kidney Transplantation | 6 | 2024 | 696 | 0.570 |
Why?
| | Tenotomy | 1 | 2018 | 15 | 0.570 |
Why?
| | Swimming | 1 | 2018 | 50 | 0.560 |
Why?
| | Prosthesis Failure | 5 | 2015 | 123 | 0.560 |
Why?
| | Pain, Postoperative | 2 | 2018 | 271 | 0.560 |
Why?
| | Venous Thromboembolism | 1 | 2022 | 314 | 0.550 |
Why?
| | Adipose Tissue | 6 | 2025 | 642 | 0.550 |
Why?
| | Carcinoma, Renal Cell | 4 | 2019 | 214 | 0.550 |
Why?
| | Glenoid Cavity | 2 | 2015 | 7 | 0.550 |
Why?
| | Yoga | 1 | 2018 | 32 | 0.550 |
Why?
| | Facial Recognition | 1 | 2018 | 32 | 0.550 |
Why?
| | Treatment Failure | 6 | 2020 | 338 | 0.550 |
Why?
| | Leg Injuries | 1 | 2017 | 24 | 0.540 |
Why?
| | Imaging, Three-Dimensional | 4 | 2018 | 562 | 0.540 |
Why?
| | Bone Density | 2 | 2021 | 488 | 0.540 |
Why?
| | Facial Expression | 1 | 2018 | 72 | 0.540 |
Why?
| | Fractures, Stress | 1 | 2017 | 33 | 0.540 |
Why?
| | Stress, Mechanical | 3 | 2019 | 482 | 0.530 |
Why?
| | Bundle of His | 1 | 2017 | 18 | 0.530 |
Why?
| | Olecranon Process | 1 | 2017 | 7 | 0.530 |
Why?
| | Muscle, Skeletal | 8 | 2020 | 1712 | 0.520 |
Why?
| | Ulna Fractures | 1 | 2017 | 13 | 0.520 |
Why?
| | Mesenchymal Stem Cell Transplantation | 3 | 2025 | 51 | 0.520 |
Why?
| | Fractures, Ununited | 1 | 2017 | 26 | 0.520 |
Why?
| | Prosthesis-Related Infections | 2 | 2015 | 98 | 0.520 |
Why?
| | Bicycling | 1 | 2017 | 111 | 0.520 |
Why?
| | Injections, Intra-Articular | 9 | 2025 | 49 | 0.520 |
Why?
| | Open Fracture Reduction | 1 | 2017 | 31 | 0.510 |
Why?
| | Social Perception | 1 | 2018 | 108 | 0.510 |
Why?
| | Hip | 3 | 2014 | 56 | 0.510 |
Why?
| | Cumulative Trauma Disorders | 1 | 2017 | 42 | 0.510 |
Why?
| | Consensus | 6 | 2025 | 675 | 0.510 |
Why?
| | Atrioventricular Block | 1 | 2017 | 37 | 0.510 |
Why?
| | Chondrocytes | 2 | 2018 | 212 | 0.510 |
Why?
| | Databases, Factual | 10 | 2019 | 1367 | 0.510 |
Why?
| | Osteosarcoma | 2 | 2015 | 73 | 0.490 |
Why?
| | Kidney Neoplasms | 4 | 2019 | 395 | 0.480 |
Why?
| | Soft Tissue Injuries | 1 | 2016 | 32 | 0.480 |
Why?
| | Patellar Ligament | 2 | 2014 | 24 | 0.470 |
Why?
| | Transplantation, Autologous | 6 | 2023 | 239 | 0.470 |
Why?
| | Stereotyping | 1 | 2015 | 44 | 0.470 |
Why?
| | Electrocardiography | 5 | 2017 | 607 | 0.460 |
Why?
| | Comprehension | 2 | 2014 | 174 | 0.460 |
Why?
| | Bone-Patellar Tendon-Bone Grafts | 1 | 2014 | 2 | 0.460 |
Why?
| | Transcatheter Aortic Valve Replacement | 1 | 2017 | 130 | 0.450 |
Why?
| | Prejudice | 1 | 2015 | 74 | 0.450 |
Why?
| | Cohort Studies | 14 | 2023 | 5688 | 0.450 |
Why?
| | Incidence | 12 | 2022 | 2793 | 0.450 |
Why?
| | Ilium | 1 | 2014 | 26 | 0.440 |
Why?
| | Fracture Fixation, Internal | 1 | 2017 | 187 | 0.440 |
Why?
| | Arthroplasty, Replacement | 5 | 2016 | 46 | 0.440 |
Why?
| | Blood Pressure Monitoring, Ambulatory | 5 | 2023 | 87 | 0.440 |
Why?
| | Patient Education as Topic | 4 | 2024 | 767 | 0.440 |
Why?
| | Hip Injuries | 1 | 2014 | 15 | 0.430 |
Why?
| | Image Processing, Computer-Assisted | 3 | 2014 | 746 | 0.430 |
Why?
| | Patellofemoral Joint | 2 | 2023 | 8 | 0.420 |
Why?
| | Blood Pressure | 9 | 2025 | 1786 | 0.420 |
Why?
| | Retroperitoneal Neoplasms | 2 | 2013 | 20 | 0.420 |
Why?
| | Child | 50 | 2025 | 21760 | 0.420 |
Why?
| | Hip Prosthesis | 1 | 2014 | 45 | 0.420 |
Why?
| | Patient Satisfaction | 3 | 2018 | 671 | 0.410 |
Why?
| | Materials Testing | 2 | 2017 | 349 | 0.410 |
Why?
| | Delphi Technique | 9 | 2025 | 277 | 0.410 |
Why?
| | Time-to-Treatment | 1 | 2015 | 203 | 0.400 |
Why?
| | Body Mass Index | 6 | 2025 | 2416 | 0.400 |
Why?
| | Models, Educational | 1 | 2013 | 93 | 0.400 |
Why?
| | Computer-Assisted Instruction | 1 | 2013 | 67 | 0.400 |
Why?
| | Graft Survival | 6 | 2019 | 523 | 0.400 |
Why?
| | Bone and Bones | 1 | 2016 | 318 | 0.400 |
Why?
| | Recurrence | 15 | 2023 | 1059 | 0.390 |
Why?
| | Models, Anatomic | 1 | 2013 | 84 | 0.390 |
Why?
| | Liposarcoma | 1 | 2013 | 27 | 0.390 |
Why?
| | Pain Management | 2 | 2014 | 363 | 0.390 |
Why?
| | Postoperative Period | 8 | 2019 | 338 | 0.390 |
Why?
| | Pain Measurement | 9 | 2025 | 524 | 0.390 |
Why?
| | Risk Factors | 24 | 2024 | 10363 | 0.390 |
Why?
| | Education, Medical, Continuing | 1 | 2013 | 127 | 0.390 |
Why?
| | Emotions | 1 | 2018 | 557 | 0.380 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 54 | 0.380 |
Why?
| | Acetabulum | 2 | 2014 | 105 | 0.380 |
Why?
| | Autism Spectrum Disorder | 1 | 2018 | 400 | 0.380 |
Why?
| | Femur Neck | 1 | 2012 | 61 | 0.380 |
Why?
| | Femur Head | 1 | 2012 | 41 | 0.380 |
Why?
| | Ozone | 3 | 2001 | 134 | 0.380 |
Why?
| | Nephrectomy | 2 | 2013 | 156 | 0.380 |
Why?
| | Universities | 1 | 2014 | 442 | 0.370 |
Why?
| | Magnetic Resonance Imaging | 6 | 2025 | 3574 | 0.360 |
Why?
| | Musculoskeletal System | 2 | 2022 | 48 | 0.360 |
Why?
| | Rotation | 3 | 2018 | 118 | 0.350 |
Why?
| | Hyaluronic Acid | 7 | 2025 | 225 | 0.350 |
Why?
| | Tomography, X-Ray Computed | 9 | 2020 | 2654 | 0.350 |
Why?
| | Age Factors | 11 | 2019 | 3258 | 0.340 |
Why?
| | Nephrotic Syndrome | 4 | 2022 | 38 | 0.340 |
Why?
| | Activities of Daily Living | 4 | 2018 | 415 | 0.330 |
Why?
| | Surveys and Questionnaires | 8 | 2022 | 5812 | 0.330 |
Why?
| | Football | 3 | 2017 | 82 | 0.330 |
Why?
| | Aged, 80 and over | 22 | 2021 | 7559 | 0.320 |
Why?
| | Stem Cell Transplantation | 3 | 2020 | 177 | 0.320 |
Why?
| | Random Allocation | 4 | 2019 | 352 | 0.310 |
Why?
| | Joint Prosthesis | 3 | 2015 | 21 | 0.310 |
Why?
| | Reproducibility of Results | 9 | 2024 | 3266 | 0.310 |
Why?
| | Meniscectomy | 2 | 2019 | 8 | 0.310 |
Why?
| | Health Care Surveys | 3 | 2017 | 564 | 0.310 |
Why?
| | United States | 21 | 2024 | 14945 | 0.310 |
Why?
| | Pilot Projects | 7 | 2021 | 1730 | 0.300 |
Why?
| | Hypertrophy, Left Ventricular | 3 | 2023 | 132 | 0.290 |
Why?
| | Sex Factors | 6 | 2019 | 2060 | 0.290 |
Why?
| | Physical Therapy Modalities | 3 | 2023 | 307 | 0.290 |
Why?
| | Patient Readmission | 3 | 2018 | 699 | 0.270 |
Why?
| | Mass Screening | 2 | 2014 | 1295 | 0.270 |
Why?
| | Joint Diseases | 3 | 2019 | 59 | 0.260 |
Why?
| | Nephrology | 2 | 2024 | 61 | 0.260 |
Why?
| | Glomerulosclerosis, Focal Segmental | 4 | 2016 | 45 | 0.250 |
Why?
| | Ambulatory Surgical Procedures | 2 | 2017 | 64 | 0.250 |
Why?
| | Arthralgia | 2 | 2025 | 54 | 0.250 |
Why?
| | Risk Assessment | 9 | 2025 | 3446 | 0.250 |
Why?
| | Patient Positioning | 2 | 2019 | 65 | 0.250 |
Why?
| | Infant Mortality | 2 | 2004 | 114 | 0.240 |
Why?
| | Video Recording | 2 | 2024 | 177 | 0.240 |
Why?
| | Matched-Pair Analysis | 2 | 2016 | 38 | 0.240 |
Why?
| | Electrocoagulation | 4 | 2014 | 39 | 0.230 |
Why?
| | Pulmonary Embolism | 3 | 2018 | 230 | 0.230 |
Why?
| | Wound Healing | 3 | 2013 | 332 | 0.230 |
Why?
| | Complement Activation | 2 | 2025 | 407 | 0.220 |
Why?
| | Humeral Fractures | 2 | 2017 | 46 | 0.220 |
Why?
| | Tachycardia, Ventricular | 4 | 2000 | 169 | 0.220 |
Why?
| | Viscosupplements | 3 | 2020 | 11 | 0.220 |
Why?
| | Time Factors | 18 | 2019 | 6786 | 0.220 |
Why?
| | Catheter Ablation | 5 | 2000 | 330 | 0.220 |
Why?
| | Clinical Trials as Topic | 2 | 2020 | 1019 | 0.220 |
Why?
| | Complement Factor H | 1 | 2025 | 79 | 0.220 |
Why?
| | Synovial Membrane | 1 | 2025 | 116 | 0.220 |
Why?
| | Curriculum | 2 | 2021 | 998 | 0.220 |
Why?
| | Reading | 3 | 2014 | 135 | 0.220 |
Why?
| | Caffeine | 1 | 2024 | 67 | 0.210 |
Why?
| | Prognosis | 13 | 2020 | 3931 | 0.210 |
Why?
| | Patellar Dislocation | 1 | 2023 | 6 | 0.210 |
Why?
| | Bone Marrow | 3 | 2023 | 298 | 0.210 |
Why?
| | Prospective Studies | 10 | 2023 | 7512 | 0.210 |
Why?
| | Prehypertension | 1 | 2023 | 28 | 0.210 |
Why?
| | Heart Ventricles | 5 | 2019 | 738 | 0.210 |
Why?
| | Sutures | 3 | 2019 | 58 | 0.200 |
Why?
| | Urolithiasis | 2 | 2016 | 9 | 0.200 |
Why?
| | Debridement | 4 | 2017 | 80 | 0.200 |
Why?
| | Ankle Injuries | 1 | 2023 | 65 | 0.190 |
Why?
| | Recovery of Function | 7 | 2019 | 648 | 0.190 |
Why?
| | Postoperative Care | 4 | 2019 | 255 | 0.190 |
Why?
| | Intra-Articular Fractures | 2 | 2019 | 19 | 0.180 |
Why?
| | Oxidants, Photochemical | 1 | 2001 | 8 | 0.180 |
Why?
| | Research Design | 2 | 2018 | 1114 | 0.180 |
Why?
| | Preoperative Period | 2 | 2018 | 131 | 0.180 |
Why?
| | Cross-Sectional Studies | 9 | 2025 | 5530 | 0.180 |
Why?
| | Urinary Diversion | 2 | 1998 | 12 | 0.180 |
Why?
| | Osteoarthritis, Hip | 1 | 2021 | 46 | 0.180 |
Why?
| | Verbal Learning | 2 | 2007 | 66 | 0.170 |
Why?
| | Knee Dislocation | 1 | 2021 | 7 | 0.170 |
Why?
| | Biology | 1 | 2022 | 91 | 0.170 |
Why?
| | Arm | 2 | 2019 | 106 | 0.170 |
Why?
| | Ankle | 2 | 2019 | 60 | 0.170 |
Why?
| | Cardiovascular Diseases | 2 | 2024 | 2115 | 0.170 |
Why?
| | Drug Chronotherapy | 1 | 2020 | 1 | 0.170 |
Why?
| | Operating Rooms | 2 | 2024 | 121 | 0.170 |
Why?
| | Comorbidity | 5 | 2018 | 1626 | 0.170 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2025 | 1460 | 0.170 |
Why?
| | Arthritis, Rheumatoid | 4 | 2025 | 1156 | 0.170 |
Why?
| | Socioeconomic Factors | 2 | 2004 | 1310 | 0.160 |
Why?
| | Antihypertensive Agents | 2 | 2020 | 495 | 0.160 |
Why?
| | Echocardiography | 4 | 2020 | 639 | 0.160 |
Why?
| | Arrhythmogenic Right Ventricular Dysplasia | 1 | 2000 | 57 | 0.160 |
Why?
| | Multiple Trauma | 1 | 2021 | 100 | 0.160 |
Why?
| | Direct-to-Consumer Advertising | 1 | 2020 | 7 | 0.160 |
Why?
| | Marketing of Health Services | 1 | 2020 | 18 | 0.160 |
Why?
| | Algorithms | 3 | 2023 | 1700 | 0.160 |
Why?
| | Autografts | 2 | 2023 | 44 | 0.160 |
Why?
| | Delayed Graft Function | 2 | 2018 | 33 | 0.160 |
Why?
| | Artificial Intelligence | 1 | 2023 | 291 | 0.160 |
Why?
| | Absorptiometry, Photon | 1 | 2021 | 264 | 0.160 |
Why?
| | Osteonecrosis | 1 | 2020 | 24 | 0.160 |
Why?
| | Kidney | 7 | 2016 | 1466 | 0.160 |
Why?
| | Intraoperative Complications | 2 | 2012 | 135 | 0.160 |
Why?
| | Spinal Neoplasms | 1 | 2019 | 34 | 0.160 |
Why?
| | Bone Substitutes | 1 | 2019 | 27 | 0.150 |
Why?
| | Kidney Diseases | 3 | 2024 | 407 | 0.150 |
Why?
| | Tensile Strength | 1 | 2019 | 94 | 0.150 |
Why?
| | Workers' Compensation | 1 | 2019 | 27 | 0.150 |
Why?
| | Surgeons | 1 | 2023 | 295 | 0.150 |
Why?
| | Pudendal Nerve | 1 | 2018 | 2 | 0.140 |
Why?
| | Graft Rejection | 3 | 2018 | 571 | 0.140 |
Why?
| | Shoulder Impingement Syndrome | 2 | 2018 | 7 | 0.140 |
Why?
| | Acromion | 2 | 2017 | 8 | 0.140 |
Why?
| | Visual Analog Scale | 1 | 2018 | 33 | 0.140 |
Why?
| | Odds Ratio | 2 | 2018 | 1071 | 0.140 |
Why?
| | Osteochondritis Dissecans | 1 | 2018 | 9 | 0.140 |
Why?
| | Prosthesis Design | 3 | 2015 | 329 | 0.140 |
Why?
| | Thinness | 1 | 2018 | 94 | 0.140 |
Why?
| | Radius | 1 | 2018 | 39 | 0.140 |
Why?
| | Mycophenolic Acid | 3 | 2008 | 117 | 0.140 |
Why?
| | Urinary Bladder Diseases | 1 | 1998 | 18 | 0.140 |
Why?
| | Immunosuppressive Agents | 3 | 2008 | 861 | 0.140 |
Why?
| | Arthrography | 1 | 2017 | 17 | 0.140 |
Why?
| | Spine | 1 | 2019 | 175 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2020 | 243 | 0.140 |
Why?
| | Sleep Wake Disorders | 1 | 2021 | 300 | 0.140 |
Why?
| | Bone Marrow Transplantation | 1 | 2019 | 287 | 0.140 |
Why?
| | Length of Stay | 3 | 2018 | 1192 | 0.140 |
Why?
| | Hospital Charges | 1 | 2017 | 41 | 0.130 |
Why?
| | Surgical Wound Infection | 3 | 2018 | 304 | 0.130 |
Why?
| | Multiple Sclerosis | 3 | 2008 | 457 | 0.130 |
Why?
| | Anticoagulants | 1 | 2022 | 652 | 0.130 |
Why?
| | Bronchi | 2 | 1996 | 263 | 0.130 |
Why?
| | Nephrons | 1 | 2016 | 20 | 0.130 |
Why?
| | Hypercalciuria | 1 | 2016 | 2 | 0.130 |
Why?
| | Emergency Medical Services | 1 | 2023 | 556 | 0.130 |
Why?
| | Patient Safety | 1 | 2020 | 313 | 0.130 |
Why?
| | Orthopedic Fixation Devices | 1 | 2016 | 7 | 0.120 |
Why?
| | Fever | 2 | 2017 | 304 | 0.120 |
Why?
| | Dementia | 1 | 2000 | 264 | 0.120 |
Why?
| | Shoulder Fractures | 1 | 2016 | 14 | 0.120 |
Why?
| | Medical History Taking | 2 | 2014 | 117 | 0.120 |
Why?
| | Minimally Invasive Surgical Procedures | 3 | 2014 | 171 | 0.120 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2018 | 265 | 0.120 |
Why?
| | Elbow Joint | 1 | 2016 | 70 | 0.120 |
Why?
| | Child, Preschool | 18 | 2018 | 10952 | 0.120 |
Why?
| | Diagnosis, Differential | 4 | 2018 | 1470 | 0.120 |
Why?
| | Lung Diseases | 2 | 2001 | 767 | 0.120 |
Why?
| | Femoral Neck Fractures | 1 | 2015 | 21 | 0.120 |
Why?
| | Glomerular Filtration Rate | 6 | 2020 | 743 | 0.120 |
Why?
| | Case-Control Studies | 3 | 2019 | 3556 | 0.120 |
Why?
| | Respiratory Mechanics | 1 | 1995 | 63 | 0.120 |
Why?
| | Femoral Neoplasms | 1 | 2015 | 9 | 0.120 |
Why?
| | Kidney Failure, Chronic | 3 | 2018 | 569 | 0.120 |
Why?
| | Tendinopathy | 1 | 2015 | 27 | 0.120 |
Why?
| | Military Personnel | 2 | 2020 | 545 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2018 | 348 | 0.110 |
Why?
| | Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 11 | 0.110 |
Why?
| | Limb Salvage | 1 | 2015 | 63 | 0.110 |
Why?
| | Ontario | 3 | 2023 | 95 | 0.110 |
Why?
| | Fracture Fixation | 1 | 2015 | 74 | 0.110 |
Why?
| | Hemodilution | 1 | 2014 | 10 | 0.110 |
Why?
| | Journal Impact Factor | 1 | 2014 | 28 | 0.110 |
Why?
| | Menstrual Cycle | 1 | 1995 | 133 | 0.110 |
Why?
| | Arthritis | 2 | 2016 | 94 | 0.110 |
Why?
| | Hemostasis, Surgical | 1 | 2014 | 22 | 0.110 |
Why?
| | Tachycardia | 4 | 1989 | 56 | 0.110 |
Why?
| | Spinal Stenosis | 1 | 2014 | 30 | 0.110 |
Why?
| | Tourniquets | 1 | 2014 | 22 | 0.110 |
Why?
| | Running | 1 | 2016 | 228 | 0.110 |
Why?
| | Intervertebral Disc Displacement | 1 | 2014 | 40 | 0.110 |
Why?
| | Laser Coagulation | 1 | 2014 | 67 | 0.110 |
Why?
| | Diagnostic Imaging | 2 | 2014 | 329 | 0.110 |
Why?
| | Hemostatics | 1 | 2014 | 52 | 0.100 |
Why?
| | Electromyography | 1 | 2016 | 399 | 0.100 |
Why?
| | Professional Practice | 1 | 2014 | 62 | 0.100 |
Why?
| | Prostheses and Implants | 1 | 2015 | 141 | 0.100 |
Why?
| | Malnutrition | 1 | 2015 | 84 | 0.100 |
Why?
| | Blood Component Transfusion | 1 | 2014 | 84 | 0.100 |
Why?
| | Pressure | 1 | 2014 | 222 | 0.100 |
Why?
| | Circadian Rhythm | 2 | 2016 | 474 | 0.100 |
Why?
| | Prosthesis Implantation | 1 | 2015 | 151 | 0.100 |
Why?
| | Arrhythmias, Cardiac | 5 | 2001 | 326 | 0.100 |
Why?
| | Nutrition Surveys | 2 | 2025 | 270 | 0.100 |
Why?
| | Adrenal Cortex Hormones | 2 | 2015 | 488 | 0.100 |
Why?
| | Canada | 1 | 2014 | 407 | 0.100 |
Why?
| | Learning Curve | 1 | 2013 | 69 | 0.100 |
Why?
| | Athletic Performance | 1 | 2014 | 79 | 0.100 |
Why?
| | Societies, Medical | 2 | 2014 | 811 | 0.100 |
Why?
| | Health Status Disparities | 1 | 2016 | 297 | 0.100 |
Why?
| | Gait | 1 | 2016 | 297 | 0.100 |
Why?
| | Metals | 1 | 2014 | 138 | 0.100 |
Why?
| | Multivariate Analysis | 5 | 2017 | 1484 | 0.100 |
Why?
| | Arthrometry, Articular | 1 | 2012 | 9 | 0.100 |
Why?
| | Incidental Findings | 1 | 2013 | 78 | 0.100 |
Why?
| | Watchful Waiting | 1 | 2012 | 75 | 0.100 |
Why?
| | Pneumonia | 1 | 2018 | 633 | 0.090 |
Why?
| | Popliteal Vein | 1 | 2012 | 4 | 0.090 |
Why?
| | Registries | 2 | 2018 | 2048 | 0.090 |
Why?
| | Ultrasonography | 3 | 2022 | 761 | 0.090 |
Why?
| | Posterior Cruciate Ligament | 1 | 2012 | 13 | 0.090 |
Why?
| | Nutritional Status | 1 | 2015 | 348 | 0.090 |
Why?
| | Locomotion | 1 | 2012 | 106 | 0.090 |
Why?
| | Pandemics | 1 | 2020 | 1630 | 0.090 |
Why?
| | Periodicals as Topic | 1 | 2014 | 211 | 0.090 |
Why?
| | Circumcision, Male | 1 | 2011 | 14 | 0.090 |
Why?
| | Educational Measurement | 1 | 2014 | 288 | 0.090 |
Why?
| | Popliteal Artery | 1 | 2012 | 62 | 0.090 |
Why?
| | Prednisone | 3 | 2007 | 214 | 0.090 |
Why?
| | Diagnostic Errors | 1 | 2012 | 171 | 0.090 |
Why?
| | Osseointegration | 1 | 2012 | 71 | 0.090 |
Why?
| | Practice Guidelines as Topic | 3 | 2025 | 1543 | 0.090 |
Why?
| | Proteinuria | 3 | 2007 | 97 | 0.090 |
Why?
| | Policy Making | 1 | 2011 | 99 | 0.090 |
Why?
| | Sexual Behavior | 1 | 2015 | 487 | 0.090 |
Why?
| | Tooth | 2 | 1990 | 44 | 0.080 |
Why?
| | Smoking | 1 | 2018 | 1609 | 0.080 |
Why?
| | Disability Evaluation | 1 | 2012 | 293 | 0.080 |
Why?
| | Interleukin-7 | 1 | 2010 | 61 | 0.080 |
Why?
| | Ankle Joint | 2 | 2023 | 114 | 0.080 |
Why?
| | Practice Patterns, Physicians' | 2 | 2014 | 1295 | 0.080 |
Why?
| | Reference Standards | 1 | 2010 | 183 | 0.080 |
Why?
| | Upper Extremity | 1 | 2010 | 100 | 0.080 |
Why?
| | Preventive Health Services | 1 | 2011 | 153 | 0.080 |
Why?
| | Lead | 1 | 1990 | 64 | 0.080 |
Why?
| | Bicuspid | 2 | 1988 | 17 | 0.080 |
Why?
| | Molar | 2 | 1988 | 48 | 0.080 |
Why?
| | Cancer Vaccines | 1 | 2010 | 164 | 0.080 |
Why?
| | Fractures, Bone | 1 | 2014 | 381 | 0.080 |
Why?
| | Biopsy, Needle | 1 | 2009 | 185 | 0.070 |
Why?
| | Vascular Surgical Procedures | 1 | 2012 | 308 | 0.070 |
Why?
| | Referral and Consultation | 2 | 2012 | 779 | 0.070 |
Why?
| | Naturopathy | 1 | 2008 | 1 | 0.070 |
Why?
| | Transplant Recipients | 2 | 2022 | 183 | 0.070 |
Why?
| | Sepsis | 1 | 2015 | 596 | 0.070 |
Why?
| | Pesticide Residues | 1 | 1988 | 4 | 0.070 |
Why?
| | Transillumination | 1 | 1988 | 3 | 0.070 |
Why?
| | Mexico | 2 | 2004 | 231 | 0.070 |
Why?
| | Urologic Diseases | 1 | 2008 | 39 | 0.070 |
Why?
| | Heart Arrest | 2 | 2012 | 336 | 0.070 |
Why?
| | Urography | 2 | 1998 | 17 | 0.070 |
Why?
| | Quality Improvement | 1 | 2016 | 1178 | 0.070 |
Why?
| | Spirometry | 2 | 2001 | 260 | 0.070 |
Why?
| | Neuropsychological Tests | 2 | 2019 | 1046 | 0.070 |
Why?
| | Rheumatoid Factor | 3 | 2025 | 175 | 0.070 |
Why?
| | Insecticides | 1 | 1988 | 42 | 0.070 |
Why?
| | Glomerulonephritis, Membranous | 1 | 2007 | 2 | 0.070 |
Why?
| | Leptospira interrogans | 2 | 1985 | 4 | 0.070 |
Why?
| | Systole | 2 | 2019 | 182 | 0.070 |
Why?
| | Diagnostic Tests, Routine | 1 | 2008 | 110 | 0.070 |
Why?
| | Hospitalization | 3 | 2016 | 2182 | 0.070 |
Why?
| | Ginkgo biloba | 1 | 2007 | 8 | 0.070 |
Why?
| | Dental Caries | 2 | 1988 | 171 | 0.070 |
Why?
| | Severity of Illness Index | 5 | 2016 | 2809 | 0.070 |
Why?
| | Creatinine | 3 | 2008 | 486 | 0.070 |
Why?
| | Logistic Models | 3 | 2015 | 2066 | 0.060 |
Why?
| | HLA-DR Antigens | 2 | 1997 | 226 | 0.060 |
Why?
| | Lysholm Knee Score | 2 | 2016 | 8 | 0.060 |
Why?
| | Milk, Human | 1 | 1988 | 156 | 0.060 |
Why?
| | Reagent Strips | 1 | 2006 | 8 | 0.060 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2001 | 639 | 0.060 |
Why?
| | Fatigue | 1 | 2008 | 337 | 0.060 |
Why?
| | Urine | 1 | 2006 | 59 | 0.060 |
Why?
| | Depressive Disorder | 2 | 2006 | 386 | 0.060 |
Why?
| | Dental Enamel | 3 | 1990 | 68 | 0.060 |
Why?
| | Ligaments | 2 | 2020 | 60 | 0.060 |
Why?
| | Nephrosis, Lipoid | 1 | 2005 | 10 | 0.060 |
Why?
| | Sleep | 2 | 2022 | 788 | 0.060 |
Why?
| | Obesity | 1 | 2018 | 3023 | 0.060 |
Why?
| | Return to Work | 2 | 2015 | 20 | 0.060 |
Why?
| | Hyperparathyroidism | 1 | 2004 | 11 | 0.060 |
Why?
| | Plant Extracts | 1 | 2007 | 206 | 0.060 |
Why?
| | Patient Selection | 2 | 2025 | 685 | 0.060 |
Why?
| | Lung | 2 | 1995 | 4035 | 0.060 |
Why?
| | Shoulder Pain | 2 | 2018 | 34 | 0.060 |
Why?
| | History, 21st Century | 1 | 2025 | 213 | 0.050 |
Why?
| | Leukocytes | 1 | 2006 | 307 | 0.050 |
Why?
| | Probability | 2 | 2006 | 306 | 0.050 |
Why?
| | Cognition Disorders | 1 | 2008 | 502 | 0.050 |
Why?
| | Maternal Age | 1 | 2004 | 127 | 0.050 |
Why?
| | Regression Analysis | 4 | 2016 | 1007 | 0.050 |
Why?
| | Weil Disease | 1 | 1983 | 1 | 0.050 |
Why?
| | Acidosis, Renal Tubular | 1 | 2003 | 4 | 0.050 |
Why?
| | Joint Capsule | 2 | 2016 | 10 | 0.050 |
Why?
| | Peripheral Nerve Injuries | 2 | 2017 | 36 | 0.050 |
Why?
| | Parathyroid Hormone | 1 | 2004 | 110 | 0.050 |
Why?
| | Health Status | 2 | 2008 | 817 | 0.050 |
Why?
| | Failure to Thrive | 1 | 2003 | 29 | 0.050 |
Why?
| | Social Justice | 1 | 2004 | 77 | 0.050 |
Why?
| | Radionuclide Angiography | 2 | 2001 | 3 | 0.050 |
Why?
| | Bicarbonates | 1 | 2003 | 45 | 0.050 |
Why?
| | Felodipine | 1 | 2003 | 4 | 0.050 |
Why?
| | Vesico-Ureteral Reflux | 1 | 2003 | 32 | 0.050 |
Why?
| | Blood Chemical Analysis | 1 | 2003 | 106 | 0.050 |
Why?
| | Antibodies, Bacterial | 1 | 1983 | 146 | 0.050 |
Why?
| | Immobilization | 1 | 2023 | 45 | 0.050 |
Why?
| | Urinalysis | 2 | 2016 | 76 | 0.050 |
Why?
| | Injections | 1 | 2023 | 182 | 0.050 |
Why?
| | Evaluation Studies as Topic | 3 | 1998 | 171 | 0.050 |
Why?
| | Receptors, Cholecystokinin | 1 | 2002 | 9 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2002 | 10 | 0.050 |
Why?
| | Leukocyte Count | 1 | 2023 | 318 | 0.050 |
Why?
| | Dyslipidemias | 1 | 2024 | 178 | 0.050 |
Why?
| | Hormone Antagonists | 1 | 2002 | 34 | 0.050 |
Why?
| | Tomography, Emission-Computed | 1 | 2002 | 67 | 0.050 |
Why?
| | Nephritis, Hereditary | 1 | 2002 | 2 | 0.050 |
Why?
| | Enalapril | 1 | 2002 | 16 | 0.050 |
Why?
| | American Heart Association | 1 | 2023 | 301 | 0.050 |
Why?
| | Infant | 8 | 2013 | 9392 | 0.050 |
Why?
| | Environmental Exposure | 2 | 2001 | 573 | 0.050 |
Why?
| | Emergencies | 1 | 2023 | 166 | 0.050 |
Why?
| | Thiazoles | 1 | 2002 | 125 | 0.050 |
Why?
| | Nitrites | 1 | 2002 | 84 | 0.050 |
Why?
| | Forecasting | 1 | 2023 | 386 | 0.050 |
Why?
| | Vaccines, Conjugate | 1 | 2002 | 64 | 0.050 |
Why?
| | Radiopharmaceuticals | 1 | 2002 | 173 | 0.050 |
Why?
| | Airway Resistance | 1 | 2001 | 40 | 0.050 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2002 | 134 | 0.040 |
Why?
| | Analysis of Variance | 4 | 2011 | 1301 | 0.040 |
Why?
| | Confidence Intervals | 2 | 2016 | 331 | 0.040 |
Why?
| | Meningococcal Vaccines | 1 | 2002 | 64 | 0.040 |
Why?
| | Weight-Bearing | 2 | 2013 | 173 | 0.040 |
Why?
| | Sensitivity and Specificity | 3 | 2018 | 1923 | 0.040 |
Why?
| | Dentin | 2 | 1990 | 22 | 0.040 |
Why?
| | Urinary Tract Infections | 1 | 2003 | 187 | 0.040 |
Why?
| | Albuminuria | 1 | 2002 | 186 | 0.040 |
Why?
| | Respiration | 1 | 2001 | 203 | 0.040 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2002 | 195 | 0.040 |
Why?
| | Bartter Syndrome | 1 | 2000 | 8 | 0.040 |
Why?
| | Heart Function Tests | 1 | 2000 | 55 | 0.040 |
Why?
| | Antibiotic Prophylaxis | 1 | 2002 | 116 | 0.040 |
Why?
| | Heart Diseases | 1 | 2004 | 325 | 0.040 |
Why?
| | Pneumococcal Vaccines | 1 | 2002 | 134 | 0.040 |
Why?
| | Cognition | 2 | 2007 | 1171 | 0.040 |
Why?
| | Poverty | 1 | 2004 | 522 | 0.040 |
Why?
| | Renal Artery Obstruction | 1 | 2000 | 31 | 0.040 |
Why?
| | Mental Status Schedule | 1 | 2000 | 33 | 0.040 |
Why?
| | Renal Artery | 1 | 2000 | 38 | 0.040 |
Why?
| | Language Tests | 1 | 2000 | 22 | 0.040 |
Why?
| | Consumer Product Safety | 1 | 2020 | 33 | 0.040 |
Why?
| | Predictive Value of Tests | 3 | 2001 | 1999 | 0.040 |
Why?
| | Hematopoietic Stem Cell Mobilization | 1 | 1999 | 23 | 0.040 |
Why?
| | HIV Infections | 2 | 2011 | 2898 | 0.040 |
Why?
| | Seizures | 1 | 2023 | 427 | 0.040 |
Why?
| | Bacterial Infections | 1 | 2002 | 243 | 0.040 |
Why?
| | Polycystic Kidney, Autosomal Dominant | 1 | 2003 | 260 | 0.040 |
Why?
| | Aggrecans | 1 | 2019 | 14 | 0.040 |
Why?
| | Pediatrics | 2 | 2024 | 1061 | 0.040 |
Why?
| | Quality of Life | 2 | 2015 | 2899 | 0.040 |
Why?
| | Survival Rate | 2 | 2001 | 1882 | 0.040 |
Why?
| | Elective Surgical Procedures | 1 | 2020 | 180 | 0.040 |
Why?
| | Vitamin E | 1 | 1999 | 122 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2002 | 483 | 0.040 |
Why?
| | Lymphoma, Non-Hodgkin | 1 | 1999 | 85 | 0.040 |
Why?
| | Chronic Traumatic Encephalopathy | 1 | 2019 | 17 | 0.040 |
Why?
| | United Kingdom | 1 | 2020 | 315 | 0.040 |
Why?
| | Urinary Bladder | 2 | 1998 | 184 | 0.040 |
Why?
| | Diastole | 1 | 2019 | 144 | 0.040 |
Why?
| | Proteoglycans | 1 | 2019 | 107 | 0.040 |
Why?
| | Depression | 1 | 2008 | 1454 | 0.040 |
Why?
| | Serum | 1 | 2019 | 59 | 0.040 |
Why?
| | Research Subjects | 1 | 2018 | 43 | 0.040 |
Why?
| | Calcium | 1 | 2004 | 1180 | 0.040 |
Why?
| | Ventricular Dysfunction, Right | 1 | 2001 | 229 | 0.040 |
Why?
| | ROC Curve | 1 | 2000 | 554 | 0.040 |
Why?
| | Thigh | 1 | 2018 | 48 | 0.040 |
Why?
| | Deltoid Muscle | 1 | 2017 | 6 | 0.040 |
Why?
| | Benzophenones | 1 | 2017 | 16 | 0.040 |
Why?
| | Pectoralis Muscles | 1 | 2017 | 18 | 0.030 |
Why?
| | Cystoscopy | 1 | 1998 | 23 | 0.030 |
Why?
| | Radiographic Image Enhancement | 1 | 1998 | 58 | 0.030 |
Why?
| | Sciatic Nerve | 1 | 2018 | 58 | 0.030 |
Why?
| | Anatomic Landmarks | 1 | 2017 | 29 | 0.030 |
Why?
| | Dissection | 1 | 2018 | 55 | 0.030 |
Why?
| | Demography | 1 | 2018 | 295 | 0.030 |
Why?
| | Brachial Plexus | 1 | 2017 | 28 | 0.030 |
Why?
| | HLA-DP Antigens | 1 | 1997 | 33 | 0.030 |
Why?
| | Torque | 1 | 2017 | 84 | 0.030 |
Why?
| | Ketones | 1 | 2017 | 47 | 0.030 |
Why?
| | Biomarkers | 3 | 2019 | 4095 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2025 | 2788 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2000 | 1251 | 0.030 |
Why?
| | Tarsal Bones | 1 | 2016 | 13 | 0.030 |
Why?
| | White Coat Hypertension | 1 | 2016 | 7 | 0.030 |
Why?
| | Adaptation, Psychological | 1 | 2022 | 669 | 0.030 |
Why?
| | Glucose | 1 | 2002 | 1029 | 0.030 |
Why?
| | User-Computer Interface | 1 | 1998 | 160 | 0.030 |
Why?
| | HLA-DQ Antigens | 1 | 1997 | 177 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2019 | 268 | 0.030 |
Why?
| | Respiratory Function Tests | 2 | 1996 | 559 | 0.030 |
Why?
| | Neuroimaging | 1 | 2019 | 261 | 0.030 |
Why?
| | Hominidae | 1 | 1997 | 86 | 0.030 |
Why?
| | Inspiratory Capacity | 1 | 1996 | 3 | 0.030 |
Why?
| | Chronic Disease | 1 | 2022 | 1774 | 0.030 |
Why?
| | Atmosphere Exposure Chambers | 1 | 1995 | 7 | 0.030 |
Why?
| | Tissue Donors | 1 | 2019 | 412 | 0.030 |
Why?
| | Frontal Lobe | 1 | 1997 | 154 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1226 | 0.030 |
Why?
| | Antioxidants | 1 | 1999 | 588 | 0.030 |
Why?
| | Lung Volume Measurements | 1 | 1995 | 45 | 0.030 |
Why?
| | Hemodynamics | 1 | 2000 | 1062 | 0.030 |
Why?
| | Blood Pressure Determination | 1 | 2016 | 160 | 0.030 |
Why?
| | Adenocarcinoma | 1 | 2002 | 869 | 0.030 |
Why?
| | Blood Glucose | 1 | 2025 | 2184 | 0.030 |
Why?
| | Endoscopy | 1 | 1998 | 310 | 0.030 |
Why?
| | Synovitis, Pigmented Villonodular | 1 | 2015 | 3 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2004 | 6051 | 0.030 |
Why?
| | Ossification, Heterotopic | 1 | 2015 | 16 | 0.030 |
Why?
| | Pulmonary Ventilation | 1 | 1995 | 80 | 0.030 |
Why?
| | Hypertrophy, Right Ventricular | 1 | 1995 | 145 | 0.030 |
Why?
| | Capillary Permeability | 1 | 1995 | 143 | 0.030 |
Why?
| | Contraindications | 1 | 2015 | 88 | 0.030 |
Why?
| | Dental Pulp | 1 | 1974 | 4 | 0.030 |
Why?
| | Remission, Spontaneous | 1 | 2014 | 38 | 0.030 |
Why?
| | Radiotherapy Dosage | 1 | 2015 | 274 | 0.030 |
Why?
| | Vital Capacity | 1 | 1995 | 299 | 0.030 |
Why?
| | Essential Hypertension | 1 | 2014 | 5 | 0.030 |
Why?
| | Pancreatic Neoplasms | 1 | 2002 | 832 | 0.030 |
Why?
| | Bronchoscopy | 1 | 1995 | 216 | 0.030 |
Why?
| | Insurance, Health | 2 | 2014 | 287 | 0.030 |
Why?
| | Nutrition Assessment | 1 | 2015 | 92 | 0.030 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2015 | 107 | 0.030 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 1995 | 139 | 0.030 |
Why?
| | Caregivers | 1 | 2022 | 903 | 0.030 |
Why?
| | Wolff-Parkinson-White Syndrome | 1 | 1994 | 19 | 0.030 |
Why?
| | Periodontitis | 1 | 1974 | 53 | 0.030 |
Why?
| | Pregnancy | 2 | 2004 | 6736 | 0.030 |
Why?
| | Forced Expiratory Volume | 1 | 1995 | 474 | 0.030 |
Why?
| | Private Practice | 1 | 2014 | 21 | 0.030 |
Why?
| | Guided Tissue Regeneration | 1 | 2013 | 13 | 0.030 |
Why?
| | Linear Models | 1 | 2016 | 857 | 0.030 |
Why?
| | Urban Population | 2 | 1990 | 481 | 0.030 |
Why?
| | Bibliometrics | 1 | 2014 | 62 | 0.030 |
Why?
| | Polymers | 1 | 2017 | 489 | 0.030 |
Why?
| | Outpatients | 1 | 2017 | 405 | 0.030 |
Why?
| | Educational Status | 2 | 2013 | 473 | 0.030 |
Why?
| | Biopsy | 3 | 2007 | 1083 | 0.030 |
Why?
| | Penile Diseases | 1 | 1993 | 5 | 0.030 |
Why?
| | Histoplasmosis | 1 | 1993 | 15 | 0.030 |
Why?
| | Acute Disease | 3 | 2015 | 993 | 0.030 |
Why?
| | Electric Stimulation Therapy | 1 | 1994 | 81 | 0.030 |
Why?
| | Survival Analysis | 1 | 2016 | 1278 | 0.020 |
Why?
| | Cervical Vertebrae | 1 | 2014 | 139 | 0.020 |
Why?
| | Academies and Institutes | 1 | 2013 | 55 | 0.020 |
Why?
| | Inpatients | 1 | 2017 | 496 | 0.020 |
Why?
| | Biological Evolution | 1 | 1997 | 491 | 0.020 |
Why?
| | Polyethylene Glycols | 1 | 2017 | 631 | 0.020 |
Why?
| | Sarcoma | 1 | 2015 | 185 | 0.020 |
Why?
| | France | 2 | 1990 | 33 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 1995 | 508 | 0.020 |
Why?
| | Pulmonary Edema | 2 | 2012 | 112 | 0.020 |
Why?
| | Exercise Test | 1 | 1995 | 617 | 0.020 |
Why?
| | Bone Neoplasms | 1 | 2015 | 243 | 0.020 |
Why?
| | North America | 1 | 2013 | 308 | 0.020 |
Why?
| | Sterilization | 1 | 2012 | 23 | 0.020 |
Why?
| | Personal Health Services | 1 | 1991 | 1 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2015 | 1022 | 0.020 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2013 | 382 | 0.020 |
Why?
| | Intestinal Obstruction | 2 | 1991 | 51 | 0.020 |
Why?
| | Papua New Guinea | 1 | 2011 | 9 | 0.020 |
Why?
| | Gamma Rays | 1 | 2012 | 55 | 0.020 |
Why?
| | Health Planning Guidelines | 1 | 2011 | 25 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 785 | 0.020 |
Why?
| | Temporomandibular Joint | 1 | 1991 | 8 | 0.020 |
Why?
| | Denture, Complete | 1 | 1991 | 7 | 0.020 |
Why?
| | Mouth, Edentulous | 1 | 1991 | 10 | 0.020 |
Why?
| | Dentition | 1 | 1991 | 16 | 0.020 |
Why?
| | Mental Disorders | 1 | 2000 | 1089 | 0.020 |
Why?
| | Animals | 6 | 2019 | 36882 | 0.020 |
Why?
| | Joint Capsule Release | 1 | 2011 | 2 | 0.020 |
Why?
| | World Health Organization | 1 | 2011 | 124 | 0.020 |
Why?
| | Health Literacy | 1 | 2013 | 170 | 0.020 |
Why?
| | B7-1 Antigen | 1 | 2010 | 58 | 0.020 |
Why?
| | Rhabdomyosarcoma | 1 | 1991 | 72 | 0.020 |
Why?
| | Hospital Mortality | 1 | 2015 | 895 | 0.020 |
Why?
| | Retinoids | 1 | 1990 | 34 | 0.020 |
Why?
| | Rabbits | 1 | 2012 | 759 | 0.020 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1999 | 1680 | 0.020 |
Why?
| | Epidemiologic Methods | 2 | 1988 | 94 | 0.020 |
Why?
| | Guanylate Cyclase | 1 | 1990 | 37 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 15 | 0.020 |
Why?
| | Intestine, Small | 1 | 1991 | 155 | 0.020 |
Why?
| | Substance Abuse, Intravenous | 1 | 1991 | 116 | 0.020 |
Why?
| | Models, Animal | 1 | 2012 | 384 | 0.020 |
Why?
| | Bone Diseases | 1 | 1990 | 63 | 0.020 |
Why?
| | Diabetes Mellitus, Type 2 | 1 | 2024 | 2553 | 0.020 |
Why?
| | Health Services Needs and Demand | 1 | 2011 | 275 | 0.020 |
Why?
| | HLA Antigens | 1 | 2010 | 238 | 0.020 |
Why?
| | Equipment Failure | 1 | 2009 | 105 | 0.020 |
Why?
| | New York | 1 | 2009 | 123 | 0.020 |
Why?
| | Blood Urea Nitrogen | 1 | 2008 | 53 | 0.020 |
Why?
| | Fourier Analysis | 2 | 2001 | 41 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1085 | 0.020 |
Why?
| | Health Services Research | 1 | 2011 | 406 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1989 | 109 | 0.020 |
Why?
| | DDT | 1 | 1988 | 2 | 0.020 |
Why?
| | Polychlorinated Biphenyls | 1 | 1988 | 12 | 0.020 |
Why?
| | Transfection | 1 | 2010 | 934 | 0.020 |
Why?
| | Tooth, Deciduous | 1 | 1988 | 18 | 0.020 |
Why?
| | Preoperative Care | 1 | 2010 | 348 | 0.020 |
Why?
| | Health Policy | 1 | 2011 | 396 | 0.020 |
Why?
| | Population Surveillance | 1 | 2011 | 487 | 0.020 |
Why?
| | Hyperlipidemias | 1 | 2008 | 123 | 0.020 |
Why?
| | Michigan | 2 | 1985 | 124 | 0.020 |
Why?
| | Capsules | 1 | 2007 | 39 | 0.020 |
Why?
| | HLA-DRB1 Chains | 2 | 1997 | 110 | 0.020 |
Why?
| | Lithotripsy | 1 | 2007 | 45 | 0.020 |
Why?
| | Reference Values | 2 | 2000 | 797 | 0.020 |
Why?
| | Placebos | 1 | 2007 | 195 | 0.020 |
Why?
| | Phytotherapy | 1 | 2007 | 84 | 0.020 |
Why?
| | Public Health | 1 | 2011 | 588 | 0.020 |
Why?
| | Metabolic Diseases | 1 | 2007 | 108 | 0.020 |
Why?
| | Rodent Control | 1 | 1985 | 2 | 0.020 |
Why?
| | Angiography | 2 | 2000 | 206 | 0.020 |
Why?
| | Leptospirosis | 1 | 1985 | 8 | 0.010 |
Why?
| | Cardiomyopathies | 1 | 1989 | 324 | 0.010 |
Why?
| | Tooth Diseases | 1 | 1985 | 13 | 0.010 |
Why?
| | Cytokines | 1 | 2013 | 2070 | 0.010 |
Why?
| | Tooth Extraction | 1 | 1985 | 25 | 0.010 |
Why?
| | Amiodarone | 1 | 1985 | 26 | 0.010 |
Why?
| | Blood Gas Analysis | 2 | 2003 | 74 | 0.010 |
Why?
| | Benzofurans | 1 | 1985 | 21 | 0.010 |
Why?
| | Rural Population | 1 | 1990 | 582 | 0.010 |
Why?
| | Memory | 1 | 2007 | 252 | 0.010 |
Why?
| | Attitude to Health | 1 | 2008 | 452 | 0.010 |
Why?
| | Alleles | 2 | 1997 | 885 | 0.010 |
Why?
| | Inflammation | 1 | 1995 | 2831 | 0.010 |
Why?
| | Suburban Population | 1 | 1983 | 18 | 0.010 |
Why?
| | Self Concept | 1 | 2006 | 253 | 0.010 |
Why?
| | Serum Albumin | 1 | 2004 | 149 | 0.010 |
Why?
| | Hematocrit | 1 | 2004 | 98 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2008 | 2015 | 0.010 |
Why?
| | Exercise | 1 | 1995 | 2064 | 0.010 |
Why?
| | Occupational Diseases | 1 | 1985 | 156 | 0.010 |
Why?
| | Wounds and Injuries | 1 | 2010 | 746 | 0.010 |
Why?
| | Attention | 1 | 2007 | 440 | 0.010 |
Why?
| | Decision Making | 1 | 2011 | 935 | 0.010 |
Why?
| | Bronchopneumonia | 2 | 1973 | 6 | 0.010 |
Why?
| | Cell Line, Tumor | 1 | 2010 | 3393 | 0.010 |
Why?
| | Learning | 1 | 2007 | 412 | 0.010 |
Why?
| | Coronary Disease | 1 | 1985 | 371 | 0.010 |
Why?
| | Delayed-Action Preparations | 1 | 2003 | 173 | 0.010 |
Why?
| | Heptavalent Pneumococcal Conjugate Vaccine | 1 | 2002 | 13 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1975 | 0.010 |
Why?
| | Technetium | 1 | 2001 | 9 | 0.010 |
Why?
| | Likelihood Functions | 1 | 2001 | 143 | 0.010 |
Why?
| | Glucocorticoids | 1 | 2004 | 519 | 0.010 |
Why?
| | Ifosfamide | 1 | 1999 | 37 | 0.010 |
Why?
| | Death, Sudden, Cardiac | 1 | 2001 | 183 | 0.010 |
Why?
| | Granulocyte Colony-Stimulating Factor | 1 | 1999 | 82 | 0.010 |
Why?
| | Carboplatin | 1 | 1999 | 142 | 0.010 |
Why?
| | Etoposide | 1 | 1999 | 158 | 0.010 |
Why?
| | Collagen | 2 | 1991 | 449 | 0.010 |
Why?
| | Combined Modality Therapy | 2 | 1994 | 1215 | 0.010 |
Why?
| | Cause of Death | 1 | 2000 | 428 | 0.010 |
Why?
| | Stroke Volume | 1 | 2001 | 571 | 0.010 |
Why?
| | Disease-Free Survival | 1 | 1999 | 662 | 0.010 |
Why?
| | HLA-DQ beta-Chains | 1 | 1997 | 63 | 0.010 |
Why?
| | Prevalence | 1 | 2004 | 2732 | 0.010 |
Why?
| | Histocompatibility Testing | 1 | 1997 | 125 | 0.010 |
Why?
| | Animals, Zoo | 1 | 1997 | 15 | 0.010 |
Why?
| | Hylobates | 1 | 1997 | 8 | 0.010 |
Why?
| | Pongo pygmaeus | 1 | 1997 | 7 | 0.010 |
Why?
| | Ileum | 1 | 1998 | 109 | 0.010 |
Why?
| | HLA-DP beta-Chains | 1 | 1997 | 85 | 0.010 |
Why?
| | Gorilla gorilla | 1 | 1997 | 23 | 0.010 |
Why?
| | Linkage Disequilibrium | 1 | 1997 | 261 | 0.010 |
Why?
| | Pan troglodytes | 1 | 1997 | 66 | 0.010 |
Why?
| | Leukocytes, Mononuclear | 1 | 1999 | 561 | 0.010 |
Why?
| | Hypoxia | 3 | 1973 | 1108 | 0.010 |
Why?
| | Amino Acid Substitution | 1 | 1997 | 304 | 0.010 |
Why?
| | Macaca mulatta | 1 | 1997 | 182 | 0.010 |
Why?
| | Gene Frequency | 1 | 1997 | 505 | 0.010 |
Why?
| | Haplotypes | 1 | 1997 | 495 | 0.010 |
Why?
| | Species Specificity | 1 | 1997 | 583 | 0.010 |
Why?
| | Electric Impedance | 1 | 1996 | 106 | 0.010 |
Why?
| | Disease Susceptibility | 1 | 1997 | 347 | 0.010 |
Why?
| | Erythrocytes | 1 | 2001 | 704 | 0.010 |
Why?
| | Heart Conduction System | 2 | 1989 | 89 | 0.010 |
Why?
| | Stem Cells | 1 | 1999 | 595 | 0.010 |
Why?
| | Cell Movement | 1 | 1999 | 964 | 0.010 |
Why?
| | Signal Processing, Computer-Assisted | 1 | 1996 | 144 | 0.010 |
Why?
| | Dental Pulp Test | 1 | 1974 | 1 | 0.010 |
Why?
| | Alveolar Process | 1 | 1974 | 6 | 0.010 |
Why?
| | Tooth Mobility | 1 | 1974 | 6 | 0.010 |
Why?
| | Health Behavior | 1 | 2000 | 780 | 0.010 |
Why?
| | Polymorphism, Genetic | 1 | 1997 | 634 | 0.010 |
Why?
| | Sequence Analysis, DNA | 1 | 1997 | 824 | 0.010 |
Why?
| | Equipment Design | 1 | 1996 | 508 | 0.010 |
Why?
| | Penis | 1 | 1993 | 34 | 0.010 |
Why?
| | New York City | 1 | 1993 | 85 | 0.010 |
Why?
| | Temperature | 1 | 1996 | 669 | 0.010 |
Why?
| | Nerve Endings | 1 | 1972 | 4 | 0.010 |
Why?
| | Rib Fractures | 1 | 1972 | 31 | 0.010 |
Why?
| | Baltimore | 1 | 1991 | 55 | 0.010 |
Why?
| | Mandibular Condyle | 1 | 1991 | 6 | 0.010 |
Why?
| | Connective Tissue | 1 | 1991 | 36 | 0.010 |
Why?
| | Microscopy, Electron | 1 | 1972 | 433 | 0.010 |
Why?
| | CD4 Antigens | 1 | 1991 | 140 | 0.010 |
Why?
| | Temporal Bone | 1 | 1991 | 41 | 0.010 |
Why?
| | Atrophy | 1 | 1991 | 188 | 0.010 |
Why?
| | Nitroprusside | 1 | 1990 | 67 | 0.010 |
Why?
| | Chromatography, Affinity | 1 | 1990 | 86 | 0.010 |
Why?
| | Income | 1 | 1991 | 204 | 0.010 |
Why?
| | Chromatography, Gel | 1 | 1990 | 129 | 0.010 |
Why?
| | Solubility | 1 | 1990 | 241 | 0.000 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 1990 | 338 | 0.000 |
Why?
| | Immunoblotting | 1 | 1990 | 304 | 0.000 |
Why?
| | Disease Progression | 1 | 1997 | 2708 | 0.000 |
Why?
| | Syncope | 1 | 1989 | 52 | 0.000 |
Why?
| | Skin Diseases | 1 | 1990 | 145 | 0.000 |
Why?
| | Cardiac Pacing, Artificial | 1 | 1989 | 75 | 0.000 |
Why?
| | Calcinosis | 1 | 1990 | 234 | 0.000 |
Why?
| | Enzyme Activation | 1 | 1990 | 815 | 0.000 |
Why?
| | Cattle | 1 | 1990 | 982 | 0.000 |
Why?
| | Osteoporosis | 1 | 1990 | 241 | 0.000 |
Why?
| | Absenteeism | 1 | 1986 | 50 | 0.000 |
Why?
| | Psychotropic Drugs | 1 | 1986 | 72 | 0.000 |
Why?
| | Oral Surgical Procedures, Preprosthetic | 1 | 1985 | 1 | 0.000 |
Why?
| | Tooth Injuries | 1 | 1985 | 4 | 0.000 |
Why?
| | Tooth Eruption | 1 | 1985 | 11 | 0.000 |
Why?
| | Malocclusion | 1 | 1985 | 24 | 0.000 |
Why?
| | Periodontal Diseases | 1 | 1985 | 61 | 0.000 |
Why?
| | Asthma | 1 | 1996 | 1873 | 0.000 |
Why?
| | Heart Aneurysm | 1 | 1982 | 11 | 0.000 |
Why?
| | Ambulatory Care | 1 | 1986 | 567 | 0.000 |
Why?
| | Cryosurgery | 1 | 1982 | 44 | 0.000 |
Why?
| | Hypotension | 2 | 1972 | 114 | 0.000 |
Why?
| | Streptococcal Infections | 2 | 1973 | 149 | 0.000 |
Why?
| | Carbon Dioxide | 2 | 1973 | 266 | 0.000 |
Why?
| | Suicide | 1 | 1986 | 660 | 0.000 |
Why?
| | Respiration, Artificial | 2 | 1972 | 627 | 0.000 |
Why?
| | Rats | 1 | 1985 | 5544 | 0.000 |
Why?
| | Acid-Base Equilibrium | 1 | 1973 | 27 | 0.000 |
Why?
| | Positive-Pressure Respiration | 1 | 1973 | 81 | 0.000 |
Why?
| | Neurologic Manifestations | 1 | 1972 | 3 | 0.000 |
Why?
| | Anuria | 1 | 1972 | 3 | 0.000 |
Why?
| | Drowning | 1 | 1972 | 6 | 0.000 |
Why?
| | Embolism, Fat | 1 | 1972 | 11 | 0.000 |
Why?
| | Anti-Bacterial Agents | 2 | 1973 | 1784 | 0.000 |
Why?
| | Tracheotomy | 1 | 1972 | 24 | 0.000 |
Why?
| | Cyanosis | 1 | 1972 | 17 | 0.000 |
Why?
| | Mitral Valve Stenosis | 1 | 1972 | 19 | 0.000 |
Why?
| | Pneumococcal Infections | 1 | 1973 | 109 | 0.000 |
Why?
| | Blood Proteins | 1 | 1973 | 245 | 0.000 |
Why?
| | Shock | 1 | 1972 | 96 | 0.000 |
Why?
| | Heparin | 1 | 1972 | 250 | 0.000 |
Why?
| | Resuscitation | 1 | 1972 | 236 | 0.000 |
Why?
| | Hemorrhage | 1 | 1972 | 717 | 0.000 |
Why?
| | Pneumonia, Viral | 1 | 1972 | 367 | 0.000 |
Why?
| | Oxygen | 1 | 1972 | 946 | 0.000 |
Why?
| | Influenza, Human | 1 | 1973 | 611 | 0.000 |
Why?
| | Alcoholism | 1 | 1972 | 796 | 0.000 |
Why?
|
|
Frank's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|